← Back to headlines





Samsung Biologics Strike Enters Work-to-Rule Phase
A five-day strike at Samsung Biologics is transitioning to a work-to-rule phase as negotiations between labor and management remain deadlocked, marking the first such action in 15 years.
5 May, 04:25 — 5 May, 04:25
Related Stories
Japan and U.S. Advance $550 Billion Investment Pact Focused on AI and Chips
27m ago

Anthropic Delays AI Startup IPO to Mid-October Amid Credit Facility Deal
1h ago

Trade Negotiations Stall as U.S. Halts Antitrust Cooperation With Canada
1h ago

Corporate Executives Across Various Sectors Sell Company Stock
1h ago